← Back to Meclofenoxate

Meclofenoxate Stats & Data

Stimulant Nootropic

Anp 235 Acephen Lucidril Helfergin Centrophenoxine

PubChem CID 4039

NPS DataHub

MW257.72

FormulaC12H16ClNO3

CAS51-68-3

IUPAC2-Dimethylaminoethyl (4-chlorophenoxy)acetate

SMILESCN(C)CCOC(=O)COc1ccc(Cl)cc1

InChIKeyXZTYGFHCIAKPGJ-UHFFFAOYSA-N

Psychoactive Class Stimulant

Pharmacology

DrugBank

Receptor Profile

Receptor Actions

Other

Metabolizes into DMAE and pCPA

DMAE is converted to choline which serves as a precursor for acetylcholine synthesis

inhibits acetylcholinesterase

inhibits MAO-A and MAO-B (in vitro)

Toxicity

PsychonautWiki

Warning: contraindications for Meclofenoxate include depression, mania, epilepsy and convulsions. Meclofenoxate is non-addictive, is not known to cause harm, and has an extremely low toxicity relative to dose. Similar to many other nootropic substances, there are relatively few physical side effects associated with acute choline exposure. Various studies have shown that in reasonable doses in a particular context, it presents no negative cognitive, psychiatric or toxic physical consequences of any sort. Regardless, it is strongly recommended that one is familiar with and uses harm reduction practices when using this substance.

Effect Profile

Curated + 1 Reports

Stimulant 5.5

Moderate stimulation and focus with mild anxiety/jitters, low euphoria

Stimulation / Energy×3

Euphoria / Mood Lift×2

Focus / Productivity×2

Anxiety / Jitters×1

Based on reports from:

Erowid Experience Reports PsychonautWiki Meclofenoxate

Tolerance & Pharmacokinetics

drugs.wiki

Tolerance Decay

Full tolerance 1d Half tolerance 10d Baseline ~18d

Experience Report Analysis

Erowid

1 Reports

2000–2000 Date Range

Demographics

Gender Distribution

Reports Over Time

Read full reports on Erowid →

References

Data Sources

Cited References

← Back to Meclofenoxate